These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28334841)

  • 41. Evaluation of two immunoassay procedures for drug testing in hair samples.
    Musshoff F; Kirschbaum KM; Graumann K; Herzfeld C; Sachs H; Madea B
    Forensic Sci Int; 2012 Feb; 215(1-3):60-3. PubMed ID: 21601388
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation of Delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Dräger DrugTest.
    Laloup M; Del Mar Ramirez Fernandez M; Wood M; De Boeck G; Maes V; Samyn N
    Forensic Sci Int; 2006 Sep; 161(2-3):175-9. PubMed ID: 16842950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opiate detection in saliva and urine--a prospective comparison by gas chromatography-mass spectrometry.
    Speckl IM; Hallbach J; Guder WG; Meyer LV; Zilker T
    J Toxicol Clin Toxicol; 1999; 37(4):441-5. PubMed ID: 10465240
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunoassay for detection of cocaine/metabolites in oral fluids.
    Niedbala RS; Kardos K; Fries T; Cannon A; Davis A
    J Anal Toxicol; 2001; 25(1):62-8. PubMed ID: 11216002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers.
    Vindenes V; Lund HM; Andresen W; Gjerde H; Ikdahl SE; Christophersen AS; Øiestad EL
    Forensic Sci Int; 2012 Jun; 219(1-3):165-71. PubMed ID: 22284072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Determination of opiates in biological human samples by liquid chromatography-tandem mass spectrometry].
    Xiang P; Shen M; Shen BH; Ma D; Bu J; Jiang Y; Zhuo XY
    Fa Yi Xue Za Zhi; 2006 Feb; 22(1):52-4, 57. PubMed ID: 16524188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Performance evaluation of the DrugWipe® 5/5+ on-site oral fluid screening device.
    Pehrsson A; Blencowe T; Vimpari K; Impinen A; Gunnar T; Lillsunde P
    Int J Legal Med; 2011 Sep; 125(5):675-83. PubMed ID: 20652713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of ten oral fluid point-of-collection drug-testing devices.
    Walsh JM; Crouch DJ; Danaceau JP; Cangianelli L; Liddicoat L; Adkins R
    J Anal Toxicol; 2007; 31(1):44-54. PubMed ID: 17389083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of four oral fluid devices (DDS®, Drugtest 5000®, Drugwipe 5+® and RapidSTAT®) for on-site monitoring drugged driving in comparison with UHPLC-MS/MS analysis.
    Strano-Rossi S; Castrignanò E; Anzillotti L; Serpelloni G; Mollica R; Tagliaro F; Pascali JP; di Stefano D; Sgalla R; Chiarotti M
    Forensic Sci Int; 2012 Sep; 221(1-3):70-6. PubMed ID: 22554872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. User experience and operational feasibility of four point-of-collection oral fluid drug-testing devices according to Brazilian traffic agents.
    Pechansky F; Scherer JN; Schuch JB; Roglio V; Telles YM; Silvestrin R; Pasa G; Sousa T
    Traffic Inj Prev; 2019; 20(1):30-36. PubMed ID: 30822144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the One-Step ELISA kit for the detection of buprenorphine in urine, blood, and hair specimens.
    Cirimele V; Etienne S; Villain M; Ludes B; Kintz P
    Forensic Sci Int; 2004 Jul; 143(2-3):153-6. PubMed ID: 15240036
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Direct Injection LC-MS-MS Analysis of Opiates, Methamphetamine, Buprenorphine, Methadone and Their Metabolites in Oral Fluid from Substitution Therapy Patients.
    Liu HC; Lee HT; Hsu YC; Huang MH; Liu RH; Chen TJ; Lin DL
    J Anal Toxicol; 2015; 39(6):472-80. PubMed ID: 25935159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An automated preconcentration-derivatization system for the determination of cocaine and its metabolites in urine and illicit cocaine samples by gas chromatography/mass spectrometry.
    Cardenas S; Gallego M; Valcarcel M
    Rapid Commun Mass Spectrom; 1996; 10(6):631-6. PubMed ID: 8624416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Performance of a point-of-care device for oral fluid ketamine evaluated by a liquid chromatography-tandem mass spectrometry method.
    Tsui TK; Chan AS; Lo CW; Wong A; Wong RC; Ho CS
    J Anal Toxicol; 2012 Apr; 36(3):210-6. PubMed ID: 22417838
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Indirect competitive assays on DVD for direct multiplex detection of drugs of abuse in oral fluids.
    Zhang L; Li X; Li Y; Shi X; Yu HZ
    Anal Chem; 2015 Feb; 87(3):1896-902. PubMed ID: 25540088
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and validation of a single LC-MS/MS assay following SPE for simultaneous hair analysis of amphetamines, opiates, cocaine and metabolites.
    Imbert L; Dulaurent S; Mercerolle M; Morichon J; Lachâtre G; Gaulier JM
    Forensic Sci Int; 2014 Jan; 234():132-8. PubMed ID: 24378313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of the Cozart microplate EIA for analysis of opiates in oral fluid.
    Cooper G; Wilson L; Reid C; Baldwin D; Hand C; Spiehler V
    Forensic Sci Int; 2005 Nov; 154(2-3):240-6. PubMed ID: 16182972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suitability of SoToxa® Oral Fluid Screening Over Time: Re-Examination of Drugged Driving in Wisconsin.
    Savage T; Sanders T; Pieters R; Miles A; Barkholtz H
    J Anal Toxicol; 2022 Oct; 46(8):825-834. PubMed ID: 35767245
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A proficiency test for hair analysis in detecting drug abuse as an index of the quality of toxicologic analysis].
    Rojek S; Kłys M; Scisłowski M
    Arch Med Sadowej Kryminol; 2005; 55(3):195-205. PubMed ID: 16320768
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stability of drugs of abuse in oral fluid collection devices with purpose of external quality assessment schemes.
    Ventura M; Pichini S; Ventura R; Leal S; Zuccaro P; Pacifici R; de la Torre R
    Ther Drug Monit; 2009 Apr; 31(2):277-80. PubMed ID: 19307939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.